Induction of tolerance via the respiratory mucosa

International Archives of Allergy and Immunology

Volumn 116, Issue 2, 1998, Pages 93-102

  Lowrey, Jacqueline A ^a   Savage, Nigel D L ^a   Palliser, Deborah ^a   Corsin Jimenez, Marta ^a   Forsyth, Lynn M G ^a   Hall, Gillian ^a   Lindey, Susannah ^a   Stewart, Gareth A ^a   Tan, Karen A L ^a   Hoyne, Gerard F ^a   Lamb, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Allergy; Mucosa; Th1 Th2; Tolerance

Indexed keywords

ALLERGIC REACTION; CLONAL ANERGY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW;

HUMANS; IMMUNE TOLERANCE; NASAL MUCOSA; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYSTEM; TH1 CELLS; TH2 CELLS;

EID: 7144257180     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023931     Document Type: Review

References (115)

1. Ramsdell F, Lantz T, Fowlkes B: A nondeletional mechanism of thymic self tolerance. Science 1989;246:1038-1041.
2. Smith C, Williams G, Kingston R, Jenkinson E, Owen J: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337:181-184.
3. Roberts J, Sharrow S, Singer A: Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J Exp Med 1990;171:935- 940.
4. Surh C, Sprent J: T-cel apoptosis detected in situ during positive and negative selection in the thymus (see comments). Nature 1994;372:100-103.
5. Guerder S, Meyerhoff J, Flavell R: The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1994;1:155-166.
6. Lo D, Burkly L, Widera G, Cowing C, Flavell R, Palmiter R, Brinster R: Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988; 53:159-168.
7. Morahan G, Allison J, Miller J: Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 1989;339:622-624.
8. Webb S, Morris C, Sprent J: Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 1990;63:1249-1256.
9. Rocha B, von Boehmer H: Peripheral selection of the T cell repertoire. Science 1991;251: 1225-1228.
10. Zhang L, Martin D, Fung-Leung W, Teh H, Miller R: Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. J Immunol 1992;148:3740-3745.
11. Ohashi P, Oehen S, Buerki K, Pircher H, Ohashi C, Odermatt B, Malissen B, Zinkemagel R, Hengartner H: Ablation of 'tolerance' and induction of diabetes by virus infection in virai antigen transgenic mice Cell 1991;65:305-317.
12. Oldstone M, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 1991;65:319-331.
13. Schonrich G, Kalinke U, Momburg F, Malissen M, Schmitt-Verhulst A, Malissen B, Hammerling G, Arnold B: Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991;65:293-304.
14. Schonrich G, Momburg F, Malissen M, Schmitt-Verhulst A, Malissen B, Hammerling G, Arnold B: Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol 1992; 4:581-590.
15. Scott B, Liblau R, Degermann S, Marconi L, Ogata L, Caton A, McDevitt H, Lo D: A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994;1:73-83.
16. Vidard L, Colarusso L, Benacerraf B: Specific T-cell tolerance may be preceded by a primary response. Proc Natl Acad Sci USA 1994; 91:5627-5631.
17. Holt PG, McMenamin C: Defence against allergic sensitization in the healthy lung: The role of inhalation tolerance. Clin Exp Allergy 1989; 19:255-262.
18. Mowat A: The regulation of immune responses to dietary protein antigens. Immunol Today 1987;8:93-98.
19. Wells H, Osborne T: The biological reactions of the vegetable proteins. J Infect Dis 1911;8:77-80.
20. Holt PG, Batty JE, Turner KJ: Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42:409-417.
21. Holt PG: Immunoregulation of the allergic reaction in the respiratory tract. Eur Respir J 1996;22(suppl):85-89.
22. Corrigan C: T and B lymphocytes and the development of allergic reactions. Allergy Allergic Dis 1997;1:36-57.
23. Wardlaw A, Moqbel R, Kay A: Eosinophils and the allergic inflammatory response. Allergy Allergic Dis 1997;1:171-197.
24. Okumura K, Tada T: Regulation of homocytotropic antibody formation in the rat. 3. Effect of thymectomy and splenectomy. J Immunol 1971;106:1019-1025.
25. Romagnani S: Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991;12:256-257.
26. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793.
27. Umetsu D, DeKruyff R: TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1-6.
28. Wierenga E, Snoek M, Bos J, Jansen H, Kapsenberg M: Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur J Immunol 1990;20:1519-1526.
29. Wierenga E, Sneok M, de Groot C, Chretien I, Bos J, Jansen H, Kapsenberg M: Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-4656.
30. Kapsenberg M, Wierenga E, Bos J, Jansen H: Functional subsets of allergen-reactive human CD4+ cells. Immunol Today 1991;12:392-395.
31. Wierenga E, Snoek M, Jansen H, Bos J, van Lier R, Kapsenberg M: Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991;147:2942-2949.
32. Yssel H, Johnson K, Schneider P, Wideman J, Terr A, Kastelein R, De VJ: T cell activation-inducing epitopes of the house dust mite allergen Der p 1. Proliferation and lymphokine production patterns by Der p 1-specific CD4+ T cell clones. J Immunol 1992;148:738-745.
33. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-257.
34. Robinson D, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley A, Corrigan C, Durham S, Kay A: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
35. Durham S, Ying S, Varney V, Jacobson M, Sudderick R, Mackay I, Kay A, Hamid Q: Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
36. Del Prete G, De CM, D'Elios M, Maestrelli P, Ricci M, Fabbri L, Romagnani S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993;23:1445-1449.
37. Kaltreider H: Expression of immune mechanisms in the lung. Am Rev Respir Dis 1976; 113:347-379.
38. Sedgwick JD, Holt PG: Induction of IgE-isotype specific tolerance by passive antigenic stimulation of the respiratory mucosa. Immunology 1983;50:625-630.
39. Thepen T, Van RN, Kraal G: Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989;170:499-509.
40. Holt PG: Down-regulation of immune responses in the lower respiratory tract: The role of alveolar macrophages. Clin Exp Immunol 1986;63:261-270.
41. Chelen C, Fang Y, Freeman G, Secrist H, Marshall J, Hwang P, Frankel L, DeKruyff R, Umetsu D: Human alveolar macrophates present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995;95:1415-1421.
42. Bilyk N, Holt PG: Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med 1993;177: 1773-1777.
43. Holt PG: Primary allergic sensitization to environmental antigens: Perinatal T cell priming as a determinant of responder phenotype in adulthood (comment). J Exp Med 1996;183:1297-1301.
44. Buckley RH, Seymour F, Sanal SO, Ownby DR, Becker WG: Lymphocyte responses to purified ragweed allergens in vitro. 1. Proliferative responses in normal, newborn, agammaglobulinemic, and atopic subjects. J Allergy Clin Immunol 1977;59:70-78.
45. O'Hehir R, Bal V, Quint D, Moqbel R, Kay AB, Zanders ED, Lamb JR: An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: Comparison of the response of an atopic and a non-atopic individual to Dermatophagoides spp. (house dust mite). Immunology 1989;66:499-504.
46. Garman R, Goodwin W, Lussier A, Gaudet E, Counsell C, Sheffer A, Saryan J, Condemi J, Greenstain J: The allergen specific T cell responses of atopic and nonatopic individuals. J Allergiy Clin Immunol 1990;85:200.
47. Holt P, Macaubas C: Development of long term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol 1997;9:782-787.
48. Jones AC, Miles EA, Warner JO, Colwell BM, Bryant TN, Warner JA: Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996;7:109-116.
49. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? (see comments). Immunol Today 1993;14:353-356.
50. Prescott SL, Macaubes C, Yabuhara A, Venaille TJ, Holt BJ, Habre W, Loh R, Sly PD, Holt PG: Developing patterns of T cell memory to environmental allergens in the first two years of life. Int Arch Allergy Immunol 1997;113:75-79.
51. Piccinni MP, Beloni L, Giannarini L, Livi C, Scarselli G, Romagnani S, Maggi E: Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents. Eur J Immunol 1996; 26:2293-2298.
52. Hattevig G, Kjellman B, Bjorksten B: Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993;4:182-186.
53. Rowntree S, Cogswell JJ, Platts-Mills TA, Mitchell EB: Development of IgE and IgG antibodies to food and inhalant allergens in children at risk of allergic disease. Arch Dis Child 1985; 60:727-735.
54. Ridge JP, Fuch EJ, Matzinger P: Neonatal tolerance revisited: Turning on newborn T cells with dendritic cells (see comments). Science 1996; 271:1723-1726.
55. Taylor S, Bryson YJ: Impaired production of gamme-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol 1985;134:1493-1497.
56. Wilson CB, Westall J, Johnston L, Lewis DB, Dower SK, Alpert AR: Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 1986;77:860-867.
57. Holt PG, Clough JB, Holt BJ, Baron-Hay MJ, Rose AH, Robinson BW, Thomas WR: Genetic 'risk' for atopy is associated with delayed postnatal maturation of T-cell competence. Clin Exp Allergy 1992;22:1093-1099.
58. Van Hout C, Johnson H: Synthesis of rat IgE by aerosol immunization. J Immunol 1972;108: 834-836.
59. Gerbrand J, Bienenstock J: Kinetics and localization of IgE tetanus antibody response in mice immunized by the intratracheal, intraperitoneal and subcutaneous routes. Immunology 1976; 31:913-919.
60. Mitchell G: Studies on immune responses to parasite antigens in mice. II. Aspects of the T cell dependence of circulating reagin production to Ascaris suum antigens. Int Arch Allergy Appl Immunol 1976;52:79-94.
61. McMenamin C, Pimm C, McKersey M, Holt P: Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994;265:1869-1871.
62. Holt PG, Leivers S: Tolerance induction via antigen inhalation: Isotype specificity, stability, and involvement of suppressor T cells. Int Arch Allergy Appl Immunol 1982;67:155-160.
63. Sedgwick JD, Holt PG: Down-regulation of immune responses to inhaled antigen: Studies on the mechanism of induced suppression. Immunology 1985;56:635-642.
64. Sedgwick JD, Holt PG: Induction of IgE-secreting cells and IgE isotype-specific suppressor T cells in the respiratory lymph nodes of rats in response to antigen inhalation. Cell Immunol 1985;94:182-194.
65. McMenamin C, Oliver J, Girn B, Holt BJ, Kees UR, Thomas WR, Holt PG: Regulation of T-cell sensitization at epithelial surfaces in the respiratory tract: Suppression of IgE responses to inhaled antigens by CD3+ Tcr alpha-/beta- lymphocytes (putative gamma/delta T cells). Immunology 1991;74:234-239.
66. McMenamin C, McKersey M, Kuhnlein P, Hinig T, Holt PG: Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 1995; 154:4390-4394.
67. McMenamin C, Holt PG: The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993;178:889-899.
68. Renz H, Bradley K, Saloga J, Loader J, Larsen GL, Gelfand EW: T cells expressing specific V beta elements regulate immunoglobulin E production and airways responsiveness in vivo. J Exp Med 1993;177:1175-1180.
69. Renz H, Lack G, Saloga J, Schwinzer R, Bradley K, Loader J, Kupfer A, Larsen GL, Gelfand EW: Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol 1994;152:351-360.
70. Wildner G, Hunig T, Thurau SR: Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis. Eur J Immunol 1996;26:2140-2148.
71. Ke Y, Kapp JA: Oral antigen inhibits priming of CD8+ CTL, CD4+ CTL, CD4+ T cells and antibody responses while activating CD8+ suppressor T cells. J Immunol 1996;156:916-921.
72. Barone KS, Jain SL, Michael JG: Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance. Cell Immunol 1995;163:19-29.
73. Garside P, Steel M, Liew FY, Mowat AM: CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int Immunol 1995;7:501-504.
74. Vistica BP, Chanaud NP 3rd, Felix N, Caspi RR, Rizzo LV, Nussenblatt RB, Gery I: CD8 T-cells are not essential for the induction of 'low-dose' oral tolerance. Clin Immunol Immunopathol 1996;78:196-202.
75. Miller A, Lider O, Weiner H: Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991;174:791-798.
76. Miller A, Lider O, Roberts A, Sporn M, Weiner H: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89:421-425.
77. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo V, Weiner H: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376:177-180. (Erratum appears in Nature 1995; 377:257.)
78. Friedman A, Weiner H: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994;91:6688-6692.
79. Melamed D, Friedman A: Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993;23:935-942.
80. Staines NA, Harper N, Ward FJ, Malmstrom V, Holmdahl R, Bansal S: Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol 1996;103:368-375.
81. Staines NA, Harper N, Ward FJ: Nasal tolerance to dominant and subdominant epitopes of collagen type II and protection against collagen-induced arthritis. Biochem Soc Trans 1997; 25:661-664.
82. Prakken BJ, van der Zee R, Anderton SM, van Kooten PJ, Kuis W, van Eden W: Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci USA 1997;94:3284-3289.
83. Metzler B, Wraith DC: Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity. Int Immunol 1993;5:1159-1165.
84. Dick AD, Cheng YF, McKinnon A, Liversidge J, Forrester JV: Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 1993; 77:171-175.
85. Daniel D, Wegmann DR: Intranasal administration of insulin peptide B: 9-23 protects NOD mice from diabetes. Ann NY Acad Sci 1996; 778:371-372.
86. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K: Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996; 184:2167-2174.
87. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996;183:1561-1567.
88. Erard F, Wild M, Garcia-Sanz J, Le GG: Switch of CD8 T cells to noncytolytic CD8- CD4-cells that make TH2 cytokines and help B cells. Science 1993;260:1802-1805.
89. Le Gros G, Erard F: Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: Their activation and effector functions. Curr Opin Immunol 1994;6:453-457.
90. Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 1993;11:637-685.
91. Correa I, Bix M, Liao N, Zijlstra M, Jaenisch R, Raulet D: Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice. Proc Natl Acad Sci USA 1992;89:653-657.
92. Bigby M, Markowitz J, Bleicher P, Grusby M, Simha S, Siebrecht M, Wagner M, Nagler-Anderson C, Flimcher L: Most gamma delta T cells develop normally in the absence of MHC class II molecules. J Immunol 1993;151:4465-4475.
93. Li H, Lebedeva MI, Liera AS, Fields BA, Brenners MB, Mariuzza RA: Structure of the Vδ domain of a human γδo T-cell antigen receptor. Nature 1998;391:502-505.
94. Weiner H, Friedman A, Miller A, Khoury S, alSabbagh A, Santos L, Sayegh M, Nussenblatt R, Trentham D, Hafler D: Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-837.
95. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR: Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993;178:1783-1788.
96. Hoyne GF, Askonas BA, Hetzel C, Thomas WR, Lamb JR: Regulation of house dust mite responses by intranasally administered peptide: Transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 1996;8:335-342.
97. Hoyne GF, Jarnicki AG, Thomas WR, Lamb JR: Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: A role for intramolecular epitope suppression. Int Immunol 1997; 9:1165-1173.
98. O'Hehir R, Lamb JR: Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc Natl Acad Sci USA 1990;87:8884-8888.
99. O'Hehir R, Aguilar BA, Schmidt TJ, Gollnick SO, Lamb JR: Functional inactivation of Dermatophagoides spp. (house dust mite) reactive human T-cell clones. Clin Exp Allergy 1991: 21:209-215.
100. Higgins JA, Lamb JR, Marsh SG, Tonks S, Hayball JD, Rosen-Bronson S, Bodmer JG, O'Hehir RE: Peptide-induced nonresponsiveness of HLA-DP restricted human T cells reactive with Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol 1992;90:749-756.
101. Gajewski TF, Lancki DW, Stack R, Fitch FW: 'Anergy' of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype. J Exp Med 1994;179:481-491.
102. Jenkins MK: The ups and downs of T cell costimulation. Immunity 1994;1:443-446.
103. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
104. Jenkins MK, Schwartz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165:302-319.
105. Van Wilsem E, Van Hoogstraten I, Breve J, Scheper R, Kraal G: Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:128-132.
106. Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG: la-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin Exp Allergy 1989;19:597-601.
107. Holt PG, Schon-Hegrad MA: Localization of T cells, macrophages and dendritic cells in rat respiratory tact tissue: Implications for immune function studies. Immunology 1987; 62:349-356.
108. Holt PG: Regulation of antigen-presenting cell function(s) in lung and airway tissues. Eur Respir J 1993;6:120-129.
109. Holt PG, Schon-Hagrad MA, Oliver J: MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J Exp Med 1988; 167:262-274.
110. Anderton SM, Wraith DC: Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Proc Natl Acad Sci USA 1998, in press.
111. Gaur A, Wiers B, Liu A, Rothbard J, Fathman C: Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 1992;258:1491-1494.
112. Qin S, Cobbold S, Pope H, Elliott J, Dioussis D, Davies J, Waldmann H: 'Infectious' transplantation tolerance. Science 1993;259:974-977.
113. Wong W, Morris P, Wood K: Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the identifinite survival of fully allogeneic cardiac allografts: Evidence for linked epitope suppression. Transplantation 1997;63:1490-1494.
114. Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
115. Perez V, Van PL, Biuckians A, Zheng X, Strom T, Abbas A: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997;6:411-417.